Article thumbnail

Clinical severity of dengue infections by strata of preexisting DENV and JEV immunity.

By Kathryn B. Anderson (228927), Robert V. Gibbons (110196), Stephen J. Thomas (228936), Alan L. Rothman (110222), Ananda Nisalak (20034), Ruth L. Berkelman (342704), Daniel H. Libraty (110206) and Timothy P. Endy (110211)


<p>The proportions of dengue (DENV) infections resulting in symptomatic illness (1a), hospitalized illness (1b), and dengue hemorrhagic fever (1c) are shown. Data are stratified by preexisting DENV immunity (naïve [DENV -], monotypic [DENV 1+], multitypic older and younger than 10 years of age [DENV >1+]) and preexisting Japanese encephalitis virus (JEV) neutralizing antibodies (NAbs) (positive [+] or negative [-]). The JEV NAb positive groups are indicated by hash lines for each stratum of DENV immunity. Odds ratios (ORs) estimate the odds of being experiencing the disease severity of interest (dengue hemorrhagic fever [DHF], hospitalized illness [Hosp], or symptomatic illness [Sx]) in the presence of JEV NAbs over the odds of experiencing the disease severity of interest in the absence of JEV NAbs. Values in parentheses indicate the 95% confidence intervals for the ORs. Error bars indicate the 95% confidence intervals for proportions.</p

Topics: Physiology, Biotechnology, Infectious Diseases, severity, dengue, infections, strata, preexisting, denv, jev
Year: 2013
DOI identifier: 10.1371/journal.pntd.0001311.g001
OAI identifier:
Provided by: FigShare
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • (external link)
  • Suggested articles

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.